108 related articles for article (PubMed ID: 3703184)
1. Inhibition of feeding by the C-terminal tetrapeptide fragment of cholecystokinin in a novel environment.
Kádár T; Penke B; Kovács K; Telegdy G
Neuropeptides; 1986; 7(2):97-108. PubMed ID: 3703184
[TBL] [Abstract][Full Text] [Related]
2. Depression of rat feeding in familiar and novel environment by sulfated and nonsulfated cholecystokinin octapeptide.
Kádár T; Penke B; Kovács K; Telegdy G
Physiol Behav; 1985 Mar; 34(3):395-400. PubMed ID: 4011720
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of tail-pinch-induced food intake by cholecystokinin octapeptides and their fragments.
Telegdy G; Kádár T; Kovács K; Penke B
Life Sci; 1984 Jul; 35(2):163-70. PubMed ID: 6330485
[TBL] [Abstract][Full Text] [Related]
4. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting.
Volkoff H; Eykelbosh AJ; Peter RE
Brain Res; 2003 May; 972(1-2):90-109. PubMed ID: 12711082
[TBL] [Abstract][Full Text] [Related]
5. Feeding-suppressive mechanism of sulfated cholecystokinin (26-33) in chicks.
Tachibana T; Matsuda K; Kawamura M; Ueda H; Khan MS; Cline MA
Comp Biochem Physiol A Mol Integr Physiol; 2012 Apr; 161(4):372-8. PubMed ID: 22227312
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the concentration of cholecystokinin-like immunoreactivity in plasma and food intake in male rats.
Lindén A; Södersten P
Physiol Behav; 1990 Dec; 48(6):859-63. PubMed ID: 2087518
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
Schick RR; Yaksh TL; Go VL
Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526
[TBL] [Abstract][Full Text] [Related]
8. Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor.
Britton DR; Yahiro L; Cullen MJ; Kerwin JF; Kopecka H; Nadzan AM
Pharmacol Biochem Behav; 1989 Dec; 34(4):779-83. PubMed ID: 2623030
[TBL] [Abstract][Full Text] [Related]
9. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats.
Asin KE; Gore PA; Bednarz L; Holladay M; Nadzan AM
Brain Res; 1992 Jan; 571(1):169-74. PubMed ID: 1611492
[TBL] [Abstract][Full Text] [Related]
10. Influence of oxytocin on feeding behavior in the rat.
Arletti R; Benelli A; Bertolini A
Peptides; 1989; 10(1):89-93. PubMed ID: 2748428
[TBL] [Abstract][Full Text] [Related]
11. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.
Katsuura G; Itoh S
Peptides; 1986; 7(5):809-14. PubMed ID: 3797342
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal injection of cholecystokinin elicits sleep in rabbits.
Kapás L; Obál F; Opp MR; Johannsen L; Krueger JM
Physiol Behav; 1991 Dec; 50(6):1241-4. PubMed ID: 1798781
[TBL] [Abstract][Full Text] [Related]
13. Effect of cholecystokinin tetrapeptide amide on the metabolism of 5-hydroxytryptamine in the rat brain.
Itoh S; Takashima A; Katsuura G
Neuropharmacology; 1988 Apr; 27(4):427-31. PubMed ID: 2458532
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
[TBL] [Abstract][Full Text] [Related]
15. Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice.
Kádár T; Borda L; Penke B; Kovács K; Telegdy G
Neuropeptides; 1985 Jun; 6(3):259-68. PubMed ID: 4040614
[TBL] [Abstract][Full Text] [Related]
16. Effect of cholecystokinin octapeptide analogues on food intake in the dog.
Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Oimomi M; Baba S
Am J Physiol; 1989 Oct; 257(4 Pt 2):R946-51. PubMed ID: 2802006
[TBL] [Abstract][Full Text] [Related]
17. Phoenixin-14 injected intracerebroventricularly but not intraperitoneally stimulates food intake in rats.
Schalla M; Prinz P; Friedrich T; Scharner S; Kobelt P; Goebel-Stengel M; Rose M; Stengel A
Peptides; 2017 Oct; 96():53-60. PubMed ID: 28844870
[TBL] [Abstract][Full Text] [Related]
18. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.
Rex A; Barth T; Voigt JP; Domeney AM; Fink H
Neurosci Lett; 1994 May; 172(1-2):139-42. PubMed ID: 8084519
[TBL] [Abstract][Full Text] [Related]
19. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
[TBL] [Abstract][Full Text] [Related]
20. Chronic intraventricular administration of cholecystokinin octapeptide (CCK-8) suppresses feeding in rats.
Schick RR; Stevens CW; Yaksh TL; Go VL
Brain Res; 1988 May; 448(2):294-8. PubMed ID: 3378151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
